Key result
Iron oxide nanoparticles are a new class of contrast agents captured by macrophages that can be used to detect and evaluate atherosclerotic plaques, abdominal aortic aneurysms, and inflammation.
Answers are grounded in this paper and cite their sources.
Iron oxide nanoparticles offer unique properties for molecular MRI, enabling the detection of macrophage-driven inflammation in cardiovascular diseases.
Molecular magnetic resonance imaging has recently emerged as a powerful tool for the detection and assessment of cardiovascular diseases. Contrast agents have an important role in this novel modality because molecular imaging requires highly sensitive, specific, and efficient imaging agents. Iron oxide nanoparticles (IONs) are a new class of contrast agents with unique properties that provide special opportunities in cardiovascular molecular imaging. IONs are captured by macrophages and can be successfully used in the detection and evaluation of atherosclerotic plaques, abdominal aortic aneurysms, and inflammations related to myocardial infarction. The purpose of this review is to provide a brief description of the basic characteristics of IONs, with a special focus on their role as molecular magnetic resonance imaging contrast agents and their cardiovascular applications.
No takes yet. Share an insight, caveat, or question.
Ploussi et al. (2015) conducted a review in Cardiovascular diseases. Iron oxide nanoparticles (IONs) was evaluated. Iron oxide nanoparticles are a new class of contrast agents captured by macrophages that can be used to detect and evaluate atherosclerotic plaques, abdominal aortic aneurysms, and inflammation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: